CN110898154A - Formula for treating colon malignant tumor - Google Patents
Formula for treating colon malignant tumor Download PDFInfo
- Publication number
- CN110898154A CN110898154A CN201911218915.9A CN201911218915A CN110898154A CN 110898154 A CN110898154 A CN 110898154A CN 201911218915 A CN201911218915 A CN 201911218915A CN 110898154 A CN110898154 A CN 110898154A
- Authority
- CN
- China
- Prior art keywords
- parts
- purified water
- ganoderma lucidum
- following components
- poria cocos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000011510 cancer Diseases 0.000 title claims abstract description 23
- 210000001072 colon Anatomy 0.000 title claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000008213 purified water Substances 0.000 claims abstract description 23
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 17
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 17
- 241000935235 Fritillaria meleagris Species 0.000 claims abstract description 15
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 15
- 244000197580 Poria cocos Species 0.000 claims abstract description 15
- 240000006023 Trichosanthes kirilowii Species 0.000 claims abstract description 15
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 claims abstract description 15
- 239000012634 fragment Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000004575 stone Substances 0.000 claims abstract description 7
- 241000132012 Atractylodes Species 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 24
- 239000003814 drug Substances 0.000 claims description 18
- 238000009835 boiling Methods 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 206010028980 Neoplasm Diseases 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 210000000988 bone and bone Anatomy 0.000 claims description 6
- 238000010411 cooking Methods 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 235000014347 soups Nutrition 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 4
- 230000036210 malignancy Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 239000003973 paint Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 210000001731 descending colon Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
The invention provides a formula for treating colon malignant tumor, which comprises the following components by weight: 30-50 parts of wild ganoderma lucidum, 5-8 parts of fossil fragments, 30-34 parts of trichosanthes kirilowii maxim, 20-25 parts of thunberg fritillary bulb, 12-16 parts of rhizoma pinelliae preparata, 15-20 parts of fried bighead atractylodes rhizome, 20-25 parts of poria cocos, 30-34 parts of oldenlandia diffusa, 10-15 parts of sculellaria barbata and 250 parts of purified water 200-. The invention adopts simple raw materials such as wild ganoderma lucidum, keel stone, purified water and the like, solves the problems in the prior art, has good effect on colon malignant tumor, has simple use method, and is suitable for popularization and use in society.
Description
Technical Field
The invention relates to the field of formulas, in particular to a formula for treating colon malignant tumor.
Background
Cancer is a fatal disease and one of the major causes of death worldwide. In 2004, 7.4 million people died of cancer worldwide (accounting for about 13% of the total deaths). This figure has been expected to continue to increase, and 1,200 million people are expected to die of cancer worldwide by 2030. Even though cancer mortality has remained stable in the past decade of the united states, the incidence, prevalence, and mortality of cancer is still at an increasing stage in developing countries. There is an urgent need for effective and safe cancer treatments.
To date, chemotherapy and radiation therapy are the primary treatments for cancer. These treatments are directed to rapidly proliferating cells, not to cancer cells. This is also an inherent cause of its fatal side effects and thus limits the dosage of therapeutic drugs. This in turn limits the efficacy of the treatment.
Therefore, a formulation with excellent performance for treating colon malignant tumor becomes a problem to be solved urgently in the whole society.
Disclosure of Invention
In view of the above, the present invention provides a formulation for treating colon malignant tumor, comprising the following components by weight: 30-50 parts of wild ganoderma lucidum, 5-8 parts of fossil fragments, 30-34 parts of trichosanthes kirilowii maxim, 20-25 parts of thunberg fritillary bulb, 12-16 parts of rhizoma pinelliae preparata, 15-20 parts of fried bighead atractylodes rhizome, 20-25 parts of poria cocos, 30-34 parts of oldenlandia diffusa, 10-15 parts of sculellaria barbata and 250 parts of purified water 200-.
Further, the paint comprises the following components in parts by weight: 30 parts of wild ganoderma lucidum, 5 parts of dragon bone stone, 30 parts of trichosanthes kirilowii maxim, 20 parts of thunberg fritillary bulb, 12 parts of rhizoma pinelliae preparata, 15 parts of rhizoma atractylodis macrocephalae preparata, 20 parts of poria cocos, 30 parts of oldenlandia diffusa, 10 parts of sculellaria barbata and 200 parts of purified water.
Further, the paint comprises the following components in parts by weight: 31 parts of wild ganoderma lucidum, 6 parts of fossil fragments, 31 parts of whole trichosanthes kirilowii maxim, 21 parts of thunberg fritillary bulb, 13 parts of rhizoma pinelliae preparata, 16 parts of roasted rhizoma atractylodis macrocephalae, 21 parts of poria cocos, 31 parts of oldenlandia diffusa, 11 parts of sculellaria barbata and 201 parts of purified water.
Further, the paint comprises the following components in parts by weight: 32 parts of wild ganoderma lucidum, 7 parts of dragon bone stone, 32 parts of trichosanthes kirilowii maxim, 22 parts of thunberg fritillary bulb, 14 parts of rhizoma pinelliae preparata, 17 parts of rhizoma atractylodis macrocephalae preparata, 22 parts of poria cocos, 32 parts of oldenlandia diffusa, 12 parts of sculellaria barbata and 202 parts of purified water.
Further, the paint comprises the following components in parts by weight: 33 parts of wild ganoderma lucidum, 8 parts of fossil fragments, 33 parts of whole trichosanthes kirilowii maxim, 23 parts of thunberg fritillary bulb, 15 parts of rhizoma pinelliae preparata, 18 parts of fried bighead atractylodes rhizome, 23 parts of poria cocos, 33 parts of oldenlandia diffusa, 13 parts of sculellaria barbata and 203 parts of purified water.
Further, the method comprises the following administration methods:
(1) preparing the raw materials according to the proportion, adding purified water, and boiling by fire;
(2) boiling, cooking the soup with soft fire for 40 minutes, filtering the first liquid medicine, and leaving the dregs;
(3) adding mineral water, decocting for 40 min, and filtering to obtain second medicinal liquid;
(4) mixing the first liquid medicine and the second liquid medicine, and taking out for administration three times a day.
Compared with the prior art, the invention has the advantages that: the invention adopts simple raw materials such as wild ganoderma lucidum, keel, purified water and the like, solves the problems existing in the prior art, has good effect on colon malignant tumor, and avoids the problems of side effects and the like caused by chemotherapy and radiotherapy in the prior art; the use method is simple and is suitable for popularization and use in society.
Detailed Description
The first embodiment is as follows: a formula for treating colon malignant tumor comprises the following components by weight: 30 parts of wild ganoderma lucidum, 5 parts of dragon bone stone, 30 parts of trichosanthes kirilowii maxim, 20 parts of thunberg fritillary bulb, 12 parts of rhizoma pinelliae preparata, 15 parts of rhizoma atractylodis macrocephalae preparata, 20 parts of poria cocos, 30 parts of oldenlandia diffusa, 10 parts of sculellaria barbata and 200 parts of purified water.
The preparation method comprises the following steps: preparing the raw materials according to the proportion, adding purified water, and boiling by fire; boiling, cooking the soup with soft fire for 40 minutes, filtering the first liquid medicine, and leaving the dregs; adding mineral water, decocting for 40 min, and filtering to obtain second medicinal liquid; mixing the first liquid medicine and the second liquid medicine, and taking out for administration three times a day.
Example two: a formula for treating colon malignant tumor comprises the following components by weight: 31 parts of wild ganoderma lucidum, 6 parts of fossil fragments, 31 parts of whole trichosanthes kirilowii maxim, 21 parts of thunberg fritillary bulb, 13 parts of rhizoma pinelliae preparata, 16 parts of roasted rhizoma atractylodis macrocephalae, 21 parts of poria cocos, 31 parts of oldenlandia diffusa, 11 parts of sculellaria barbata and 201 parts of purified water.
The preparation method comprises the following steps: preparing the raw materials according to the proportion, adding purified water, and boiling by fire; boiling, cooking the soup with soft fire for 40 minutes, filtering the first liquid medicine, and leaving the dregs; adding mineral water, decocting for 40 min, and filtering to obtain second medicinal liquid; mixing the first liquid medicine and the second liquid medicine, and taking out for administration three times a day.
Example three: a formula for treating colon malignant tumor comprises the following components by weight: 32 parts of wild ganoderma lucidum, 7 parts of dragon bone stone, 32 parts of trichosanthes kirilowii maxim, 22 parts of thunberg fritillary bulb, 14 parts of rhizoma pinelliae preparata, 17 parts of rhizoma atractylodis macrocephalae preparata, 22 parts of poria cocos, 32 parts of oldenlandia diffusa, 12 parts of sculellaria barbata and 202 parts of purified water.
The preparation method comprises the following steps: preparing the raw materials according to the proportion, adding purified water, and boiling by fire; boiling, cooking the soup with soft fire for 40 minutes, filtering the first liquid medicine, and leaving the dregs; adding mineral water, decocting for 40 min, and filtering to obtain second medicinal liquid; mixing the first liquid medicine and the second liquid medicine, and taking out for administration three times a day.
Example four: a formula for treating colon malignant tumor comprises the following components by weight: 33 parts of wild ganoderma lucidum, 8 parts of fossil fragments, 33 parts of whole trichosanthes kirilowii maxim, 23 parts of thunberg fritillary bulb, 15 parts of rhizoma pinelliae preparata, 18 parts of fried bighead atractylodes rhizome, 23 parts of poria cocos, 33 parts of oldenlandia diffusa, 13 parts of sculellaria barbata and 203 parts of purified water.
The preparation method comprises the following steps: preparing the raw materials according to the proportion, adding purified water, and boiling by fire; boiling, cooking the soup with soft fire for 40 minutes, filtering the first liquid medicine, and leaving the dregs; adding mineral water, decocting for 40 min, and filtering to obtain second medicinal liquid; mixing the first liquid medicine and the second liquid medicine, and taking out for administration three times a day.
The examples are as follows: the xu lady, aged 50 years old, is admitted to hospital and diagnosed as descending colon malignant tumor, and gradually gets better after taking the formula for a period of time, and finally gets well.
Having thus described the basic principles and principal features of the invention, it will be appreciated by those skilled in the art that the invention is not limited by the embodiments described above, which are given by way of illustration only, but that various changes and modifications may be made therein without departing from the spirit and scope of the invention as defined by the appended claims and their equivalents.
Claims (6)
1. A formula for treating colon malignant tumor is characterized by comprising the following components in parts by weight: 30-50 parts of wild ganoderma lucidum, 5-8 parts of fossil fragments, 30-34 parts of trichosanthes kirilowii maxim, 20-25 parts of thunberg fritillary bulb, 12-16 parts of rhizoma pinelliae preparata, 15-20 parts of fried bighead atractylodes rhizome, 20-25 parts of poria cocos, 30-34 parts of oldenlandia diffusa, 10-15 parts of sculellaria barbata and 250 parts of purified water 200-.
2. The formulation of claim 1, wherein the formulation is for use in the treatment of a colon malignancy, wherein: comprises the following components by weight: 30 parts of wild ganoderma lucidum, 5 parts of dragon bone stone, 30 parts of trichosanthes kirilowii maxim, 20 parts of thunberg fritillary bulb, 12 parts of rhizoma pinelliae preparata, 15 parts of rhizoma atractylodis macrocephalae preparata, 20 parts of poria cocos, 30 parts of oldenlandia diffusa, 10 parts of sculellaria barbata and 200 parts of purified water.
3. The formulation of claim 1, comprising the following components by weight: 31 parts of wild ganoderma lucidum, 6 parts of fossil fragments, 31 parts of whole trichosanthes kirilowii maxim, 21 parts of thunberg fritillary bulb, 13 parts of rhizoma pinelliae preparata, 16 parts of roasted rhizoma atractylodis macrocephalae, 21 parts of poria cocos, 31 parts of oldenlandia diffusa, 11 parts of sculellaria barbata and 201 parts of purified water.
4. The formulation of claim 1, comprising the following components by weight: 32 parts of wild ganoderma lucidum, 7 parts of dragon bone stone, 32 parts of trichosanthes kirilowii maxim, 22 parts of thunberg fritillary bulb, 14 parts of rhizoma pinelliae preparata, 17 parts of rhizoma atractylodis macrocephalae preparata, 22 parts of poria cocos, 32 parts of oldenlandia diffusa, 12 parts of sculellaria barbata and 202 parts of purified water.
5. The formulation of claim 1, comprising the following components by weight: 33 parts of wild ganoderma lucidum, 8 parts of fossil fragments, 33 parts of whole trichosanthes kirilowii maxim, 23 parts of thunberg fritillary bulb, 15 parts of rhizoma pinelliae preparata, 18 parts of fried bighead atractylodes rhizome, 23 parts of poria cocos, 33 parts of oldenlandia diffusa, 13 parts of sculellaria barbata and 203 parts of purified water.
6. The formulation of claim 1, comprising the following method of administration:
(1) preparing the raw materials according to the proportion, adding purified water, and boiling by fire;
(2) boiling, cooking the soup with soft fire for 40 minutes, filtering the first liquid medicine, and leaving the dregs;
(3) adding mineral water, decocting for 40 min, and filtering to obtain second medicinal liquid;
(4) mixing the first liquid medicine and the second liquid medicine, and taking out for administration three times a day.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911218915.9A CN110898154A (en) | 2019-12-03 | 2019-12-03 | Formula for treating colon malignant tumor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911218915.9A CN110898154A (en) | 2019-12-03 | 2019-12-03 | Formula for treating colon malignant tumor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110898154A true CN110898154A (en) | 2020-03-24 |
Family
ID=69821468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911218915.9A Pending CN110898154A (en) | 2019-12-03 | 2019-12-03 | Formula for treating colon malignant tumor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110898154A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450165A (en) * | 2007-11-29 | 2009-06-10 | 北京久久方元保健品经销有限公司 | Anti-cancer traditional Chinese medicine compound ganoderma preparation and preparation method thereof |
| CN105535685A (en) * | 2016-01-22 | 2016-05-04 | 广西中医药大学 | Compound traditional Chinese medicine for resisting colon cancer and preparation method thereof |
| CN107617077A (en) * | 2017-09-01 | 2018-01-23 | 李淑梅 | A kind of Chinese medicine preparation for treating malignant tumour and preparation method thereof |
| CN110193050A (en) * | 2019-07-09 | 2019-09-03 | 河南省中医院（河南中医药大学第二附属医院） | Traditional Chinese medicine composition for preventing recurrence and metastasis of digestive tract tumor and preparation method thereof |
| CN110339276A (en) * | 2019-07-17 | 2019-10-18 | 河南省中医院（河南中医药大学第二附属医院） | Traditional Chinese medicine for treating digestive tract tumor and preparation method thereof |
| CN110368475A (en) * | 2019-08-26 | 2019-10-25 | 贵州中医药大学第一附属医院 | A kind of drug and preparation method thereof for malignant tumour early stage |
-
2019
- 2019-12-03 CN CN201911218915.9A patent/CN110898154A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450165A (en) * | 2007-11-29 | 2009-06-10 | 北京久久方元保健品经销有限公司 | Anti-cancer traditional Chinese medicine compound ganoderma preparation and preparation method thereof |
| CN105535685A (en) * | 2016-01-22 | 2016-05-04 | 广西中医药大学 | Compound traditional Chinese medicine for resisting colon cancer and preparation method thereof |
| CN107617077A (en) * | 2017-09-01 | 2018-01-23 | 李淑梅 | A kind of Chinese medicine preparation for treating malignant tumour and preparation method thereof |
| CN110193050A (en) * | 2019-07-09 | 2019-09-03 | 河南省中医院（河南中医药大学第二附属医院） | Traditional Chinese medicine composition for preventing recurrence and metastasis of digestive tract tumor and preparation method thereof |
| CN110339276A (en) * | 2019-07-17 | 2019-10-18 | 河南省中医院（河南中医药大学第二附属医院） | Traditional Chinese medicine for treating digestive tract tumor and preparation method thereof |
| CN110368475A (en) * | 2019-08-26 | 2019-10-25 | 贵州中医药大学第一附属医院 | A kind of drug and preparation method thereof for malignant tumour early stage |
Non-Patent Citations (2)
| Title |
|---|
| 胡一莉,等: "萎胃方加味治疗慢性萎缩性胃炎癌前病变的临床观察", 《浙江中医杂志》 * |
| 解英，等: "中晚期癌症患者的中医辨证治疗", 《中医药研究》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104337974A (en) | Drug for treating metrorrhagia and preparation method thereof | |
| CN102119970A (en) | Chinese medicinal composition for treating myasthenia gravis | |
| CN110898154A (en) | Formula for treating colon malignant tumor | |
| CN101804126A (en) | Application of traditional Chinese medicine composition in treating qi-blood deficiency and spleen-kidney deficiency and preparation method thereof | |
| Yang | Annual advances in traditional medicine for tumor therapy in 2019 | |
| CN104306632A (en) | An antitumor medicine and a preparing method thereof | |
| CN102657816A (en) | Medicament for treating dizziness and preparation method thereof | |
| CN102600279A (en) | Traditional Chinese medicine for treating cancer | |
| CN101675961B (en) | A medicinal preparation for treating breast cancer and preparation method thereof | |
| CN103751625B (en) | A kind of Chinese medicine composition and application thereof for the treatment of epistaxis and hematemesis during menstruation | |
| CN102302542A (en) | Chinese medicinal oral liquid for treating cancers | |
| CN101954034A (en) | Chinese medicinal preparation for treating acquired immune deficiency syndrome and preparation method thereof | |
| CN104288425A (en) | Traditional Chinese medicinal ointment for treating rheumatoid disease | |
| CN1108158C (en) | Analgesic composition | |
| CN103948859A (en) | Anti-tumor traditional Chinese medicine compound preparation as well as preparation method and application thereof | |
| CN103735863A (en) | Traditional Chinese medicine composition for preventing and controlling radiation | |
| CN109316573A (en) | A kind of Chinese medicine composition and preparation method thereof for treating liver cancer | |
| CN102366619A (en) | Medicine for treating abnormal menstruation caused by asthenia of qi and blood and insomnia | |
| CN106309856A (en) | External used drug applied to cervical cancer and preparation method thereof | |
| CN106729566B (en) | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof | |
| CN102526234A (en) | Medicament for treating apoplexy and preparation method thereof | |
| CN1042495C (en) | Medicine for benefitting Qi, removing cancer and raising leucocyte and its prepn. | |
| CN109771529A (en) | Pharmaceutical composition, its extract, preparation method and application for treating brain tumor | |
| CN101152360A (en) | Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine | |
| CN106212769A (en) | Benefiting QI for activating blood circulation detumescence health preserving Tea containing traditional Chinese medicine beverage and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200324 |
|
| RJ01 | Rejection of invention patent application after publication |